One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report.
- DOI
- 10.1007/s40123-026-01344-x
- Published
- 2026 Apr
- Container
- Ophthalmology and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40123-026-01344-x,
title = {One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report.},
author = {Kitay AM and Tillmann A and Pfister I and Schild C and Bonanata M and Heck K and Spitznagel T and Gabathuler F and Bartolomeo N and Magnin S and Löliger J and Munk MR and Menghini M and Hatz K and Somfai GM and Zweifel S and Ambresin A and Eandi CM and Feltgen N and Weinberger A and Garweg JG and Kurz-Levin MM},
year = {2026},
journal = {Ophthalmology and therapy},
doi = {10.1007/s40123-026-01344-x},
url = {https://doi.org/10.1007/s40123-026-01344-x}
}RIS
TY - JOUR TI - One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report. AU - Kitay AM AU - Tillmann A AU - Pfister I AU - Schild C AU - Bonanata M AU - Heck K AU - Spitznagel T AU - Gabathuler F AU - Bartolomeo N AU - Magnin S AU - Löliger J AU - Munk MR AU - Menghini M AU - Hatz K AU - Somfai GM AU - Zweifel S AU - Ambresin A AU - Eandi CM AU - Feltgen N AU - Weinberger A AU - Garweg JG AU - Kurz-Levin MM PY - 2026 JO - Ophthalmology and therapy DO - 10.1007/s40123-026-01344-x UR - https://doi.org/10.1007/s40123-026-01344-x ER -
APA
AM, K., A, T., I, P., C, S., M, B., K, H., T, S., F, G., N, B., S, M., J, L., MR, M., M, M., K, H., GM, S., S, Z., A, A., CM, E., N, F., A, W., JG, G., & MM, K. (2026). One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report.. Ophthalmology and therapy. https://doi.org/10.1007/s40123-026-01344-x
Source records
- pubmed · retrieved 2026-09-27T00:18:06.735Z
- europe-pmc · retrieved 2026-09-27T00:18:06.752Z
- doaj · retrieved 2026-09-27T00:18:06.752Z